Earnix Study Finds Insurers Prioritize Modernization but Struggle to Implement
Nearly 90 percent of insurance carriers have not fully developed and executed their operations modernization…
Year: 2022
Celential.ai appoints Wendi Zhang as VP of Business Development and Operations to lead strategic growth and help close the tech talent gap
Wendi Zhang, former Business Development and Partnerships leader at Google’s AI-focused fund Gradient Ventures and…
Compucom Named Major Contender in Everest Group’s PEAK Matrix 2022
Report highlights Compucom’s key differentiators of user experience-focused services and strong device management FORT MILL,…
Keepit to Present at Gartner IT Infrastructure, Operations & Cloud Strategies Conference 2022
Company to Lead Speaker Session and Offer Product Demonstrations COPENHAGEN, Denmark–(BUSINESS WIRE)–#Canada—Keepit, the market leader…
Btech Consortium Launches to Advance Community Bank Technology
Consortium’s mission is to empower community banks and the local communities they serve LOS ANGELES–(BUSINESS…
Marstone Announces Marstone@WorkTM Solution Providing Digital Wealth Management Services to Corporations’ Employees
Employees of partner companies benefit from digital advice solutions offered alongside traditional financial benefits including…
Wolters Kluwer names the winner of its 2022 Alfredo deHaas Excellence in Data Analytics Award
Natalie Parker of Synovus honored at 26th Annual CRA & Fair Lending Colloquium LAS VEGAS–(BUSINESS…
BioFuture™ Conference Brings Together Stakeholders In Transformative Healthcare Summit
Event highlighted cutting-edge technology and disruptive science for breakthrough therapeutics NEW YORK–(BUSINESS WIRE)–BioFuture™, produced by…
Anode Labs Announces Funding To Build The React Network: The First Community-Owned, Web3 Green Energy Grid
The company’s React Network is aiming to modernize the national power grid by creating a…
IGEL Ends Production of IGEL-branded Hardware, Partners with Leading Device Manufacturers to Expand Global Software Reach
IGEL teams with HP, Lenovo, and LG to deliver its managed endpoint operating system, enabling…
SPR Therapeutics Debuts Occipital Nerve Stimulation Data at ASRA 2022
One of six total abstracts accepted highlighting benefits of the SPRINT® PNS System CLEVELAND, Nov….
Rakovina Therapeutics Inc. Announces Q3 2022 Financial Results and Provides Corporate Update
VANCOUVER, British Columbia, Nov. 17, 2022 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the…
RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
Glen Rock, N.J., Nov. 17, 2022 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTC Pink Market:RSPI)…
ABVC BioPharma Provides Vitargus® Update – Phase II Vitargus® Study Protocol Received Thai FDA Approval
FREMONT, CA, Nov. 17, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ:…
Kane Biotech to Release Third Quarter 2022 Financial Results on November 24, 2022 – Conference Call to Follow
WINNIPEG, Manitoba, Nov. 17, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company”…
Agenus Data at CTOS 2022 Highlight Durable Clinical Responses of Botensilimab / Balstilimab Combination in Advanced Sarcoma
Overall response rate (ORR) of 46% and disease control rate (DCR) of 69% in heavily…
IMUNON Announces Strategic Investment in Transomic Technologies
Investment of $375,000 with Senior Convertible Notes and Warrants; Strengthens Development Capabilities for IMUNON’s PLACCINE…
SCYNEXIS Applauds the Biomedical Advanced Research and Development Authority (BARDA) for Its New Priority Focus on Investment in Development of Antifungal Treatments to Fight Infections Caused by Drug-Resistant Fungal Threats
BARDA is seeking to support the development of broad-spectrum, oral/IV antifungal drug candidates with novel…
Palisade Bio Releases In-Depth Explanation of Scientific Approach of Lead Product Candidate LB1148 Through Animated Video
Video illustrates the potential of LB1148 to reduce the formation of adhesions in gastrointestinal (GI)…
VYNE Therapeutics Announces First Subjects Dosed in Phase 1a/b Clinical Trial Evaluating Pan-BET Inhibitor, VYN201, for the Treatment of Vitiligo
Topline proof-of-concept data in vitiligo patients expected in 1H 2023 BRIDGEWATER, N.J., Nov. 17, 2022…